Category: Pharma Industry

Two New Drug Industry Lawsuits Challenge 340B Contract Pharmacy Access Laws in Kansas, Missouri

August 13, 2024 William Newton, Associate Editor/Senior Writer Views

Drugmaker Novartis and trade organization PhRMA each recently filed a new lawsuit against separate state 340B contract pharmacy access laws.

A powerful brand name drug industry trade group has filed suit against a Kansas law prohibiting drugmaker 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

J&J Exempts Maryland, Mississippi from Contract Pharmacy Restrictions

August 13, 2024 William Newton, Associate Editor/Senior Writer Views

Drugmaker J&J announced for the first time that it is exempting certain states from its 340B contract pharmacy restrictions.

Pharmaceutical giant Johnson & Johnson (J&J) is exempting covered entities in Maryland and Mississippi from its contract pharmacy restrictions, marking [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Weekly Roundup: AstraZeneca Subpoenas in Arkansas, Mississippi; Minnesota AG’s Defense

August 8, 2024 William Newton and Shannon Young, Associate Editor/Senior Writer Views

Lawsuits challenging 340B contract pharmacy access laws recently heated up in Missouri, Mississippi and Maryland.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

More Drugmakers Exempt New States from 340B Contract Pharmacy Restrictions

August 6, 2024 William Newton, Associate Editor/Senior Writer Views

Sanofi was one of three drug manufacturers to recently update its contract pharmacy restrictions in response to new state laws.

Pharmaceutical manufacturers Sanofi, GlaxoSmithKline (GSK) and Viatris are fully or partially exempting additional states from their 340B contract pharmacy restrictions. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Third Drugmaker Sues Kansas Over Its 340B Contract Pharmacy Access Law

August 6, 2024 William Newton, Associate Editor/Senior Writer Views

Novartis became the third pharmaceutical manufacturer to sue Kansas over its 340B contract pharmacy access law.

Novartis is now the third drug manufacturer to challenge Kansas’ new law prohibiting drug manufacturers from restricting contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

U.S. Government, 340B Provider Groups Urge Appeals Court to Reverse Dismissal of Health System’s 340B Whistleblower Lawsuit

August 1, 2024 William Newton, Associate Editor/Senior Writer Views

Adventist Health System/West's 340B whistleblower lawsuit received four amicus briefs in support of its appeal to the U.S. 9th Circuit Court of Appeals.

The U.S. government is urging a federal appeals court to dismiss a lower court’s “erroneous” decision to dismiss a California [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

PhRMA Petitions Supreme Court to Overturn Arkansas’ 340B Contract Pharmacy Access Law

August 1, 2024 William Newton, Associate Editor/Senior Writer Views

PhRMA petitioned the U.S. Supreme Court to take a case on the constitutionality of Arkansas' 340B contract pharmacy access law.

A powerful drug industry trade group has asked the U.S. Supreme Court to overturn a federal appeals court’s decision to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Two Hospitals Sue HRSA to Block ‘Unlawfully Authorized’ Drugmaker 340B Program Audits

July 26, 2024 William Newton, Associate Editor/Senior Writer Views

Oregon Health & Science University Hospital is one of two 340B hospitals to sue HRSA over approving a drugmaker audit. (Photo by M.O. Stevens)

Two 340B hospitals urged a federal district court to block drugmaker Johnson & Johnson (J&J) from conducting “unlawfully authorized” audits [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Merck, Wisconsin Health System Join 340B Working Table; 300+ Firms Lobbied on 340B in Q2

July 25, 2024 Shannon Young, Associate Editor/Senior Writer Views

Merck and Marshfield Clinic Health System have joined the growing list of organizations in the 340B Working Table.

New Jersey-based drug manufacturing giant Merck and a large Wisconsin-based health system are the latest to join the 340B Working [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Health System Urges Federal Appeals Court to Revive 340B Overcharge Lawsuit Against Major Drugmakers

July 23, 2024 William Newton, Associate Editor/Senior Writer Views

Adventist Health System/West alleged in a lawsuit that four major drugmakers defrauded the federal government by overcharging for 340B drugs.

A California health system has urged a federal appeals court to reverse a lower court’s decision to dismiss its lawsuit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Category: Pharma Industry

Two New Drug Industry Lawsuits Challenge 340B Contract Pharmacy Access Laws in Kansas, Missouri

Please Login or Become a Paid Subscriber to View this Content

If you are already a

J&J Exempts Maryland, Mississippi from Contract Pharmacy Restrictions

Please Login or Become a Paid Subscriber to View this Content

If you are already a

State Contract Pharmacy Lawsuit Weekly Roundup: AstraZeneca Subpoenas in Arkansas, Mississippi; Minnesota AG’s Defense

Please Login or Become a Paid Subscriber to View this Content

If you are already a

More Drugmakers Exempt New States from 340B Contract Pharmacy Restrictions

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Third Drugmaker Sues Kansas Over Its 340B Contract Pharmacy Access Law

Please Login or Become a Paid Subscriber to View this Content

If you are already a

U.S. Government, 340B Provider Groups Urge Appeals Court to Reverse Dismissal of Health System’s 340B Whistleblower Lawsuit

Please Login or Become a Paid Subscriber to View this Content

If you are already a

PhRMA Petitions Supreme Court to Overturn Arkansas’ 340B Contract Pharmacy Access Law

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Two Hospitals Sue HRSA to Block ‘Unlawfully Authorized’ Drugmaker 340B Program Audits

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Merck, Wisconsin Health System Join 340B Working Table; 300+ Firms Lobbied on 340B in Q2

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Health System Urges Federal Appeals Court to Revive 340B Overcharge Lawsuit Against Major Drugmakers

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live